Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Li, Qiurong ^a   Zhang, Qiang ^a   Wang, Chenyang ^a   Tang, Chun ^a   Zhang, Yanmei ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; FISH OIL; OCCLUDIN; PROTEIN; RIBOSOME DNA; RNA 16S;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; CELL ULTRASTRUCTURE; CHRONIC GRAFT REJECTION; CLOSTRIDIUM; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIET SUPPLEMENTATION; ESCHERICHIA COLI; IMMUNOFLUORESCENCE TEST; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE TRANSPLANTATION; LACTOBACILLALES; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERMEABILITY BARRIER; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; RAT; SEQUENCE ANALYSIS; TIGHT JUNCTION; ANIMAL; CLUSTER ANALYSIS; DRUG EFFECT; GENETICS; GRAFT REJECTION; INTESTINE; MICROBIOLOGY; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TRANSPLANTATION;

BACTERIA (MICROORGANISMS); BACTEROIDES; CLOSTRIDIUM; ESCHERICHIA COLI; LACTOBACILLALES; RATTUS;

ANIMALS; CLUSTER ANALYSIS; DIETARY SUPPLEMENTS; DNA, RIBOSOMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FISH OILS; GRAFT REJECTION; INTESTINES; PHYLOGENY; RATS; RNA, RIBOSOMAL, 16S;

EID: 79959195550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020460     Document Type: Article

References (40)

1. Abu-Elmagd K, Reyes J, Bond G, Mazariegos G, Wu T, et al. (2001) Clinical intestinal trans- plantation: a decade of experience at a single center. Ann Surg 234: 404-416.
2. Niv Y, Mor E, Tzakis AG, (1999) Small bowel transplantation a clinical review. Am J Gastroenterol 94: 3126-3130.
3. Chen Y, Li XS, Tian L, Lui VCH, Dallman MJ, et al. (2007) Inhibition of sonic hedgehog signaling reduces chronic rejection and prolongs allograft survival in a rat orthotopic small bowel transplantation model. Transplantation 83: 1351-1357.
4. Sudan DL, Kaufman SS, Shaw BW Jr, Fox IJ, McCashland TM, et al. (2000) Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 95: 1506-1515.
5. Dethlefsen L, Eckburg PB, Bik EM, Relman DA, (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol 21: 517-523.
6. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-11075.
7. Reid G, Howard J, Gan BS, (2001) Can bacterial interference prevent infection? Trends Microbiol 9: 424-428.
8. Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB, (2005) Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun 73: 6952-6961.
9. Hooper LV, (2004) Bacterial contributions to mammalian gut development. Trends Microbiol 12: 129-134.
10. Vollaard EJ, Clasener HA, (1994) Colonization resistance. Antimicrob Agents Chemother 38: 409-414.
11. Balda MS, Matter K, (2000) Transmembrane proteins of tight junctions. Semin Cell Dev Biol 11: 281-289.
12. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE, (2003) Tight junction proteins. Prog Biophys Mol Biol 81: 1-44.
13. Li QR, Zhang Q, Wang M, Zhao SM, Ma J, et al. (2008) Interferon-γ and tumor necrosis factor-α disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 126: 67-80.
14. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103.
15. Li QR, Zhang Q, Wang CY, Tang C, Zhang YM, et al. (2010) Influence of alemtuzumab on the intestinal Paneth cells and microflora in macaques. Clin Immunol 136: 375-386.
16. Qu LL, Li QR, Jiang HT, Gu LL, Zhang Q, et al. (2009) Effect of anti-mouse CD52 monoclonal antibody on mouse intestinal intraepithelial lymphocytes. Transplantation 88: 766-772.
17. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, et al. (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350: 560-569.
18. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi SB, et al. (1996) Effect of an enteric coated fish oil preparation on relapses in Crohn's disease. N Engl J Med 334: 1557-1560.
19. Teitelbaum JE, Walker WA, (2001) The role of omega 3 fatty acids in intestinal inflammation. J Nutr Biochem 12: 21-32.
20. Pscheidl E, (2002) Effects of fatty acids on gut integrity and function. Clin Nutr21 (Suppl. 2): 47-51.
21. Whiting CV, Bland PW, Tarlton JF, (2005) Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm Bowel Dis 11: 340-349.
22. Li Q, Zhang Q, Wang M, Zhao SM, Xu GW, et al. (2008) n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. Mol Immunol 45: 1356-1365.
23. Kankaanpää PE, Salminen SJ, Isolauri E, Lee YK, (2001) The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett 194: 149-153.
24. Bomba A, Nemcová R, Gancarcíková S, Herich R, Guba P, et al. (2002) Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids. Br J Nutr Suppl 1 pp. S95-99.
25. Otto DA, Kahn DR, Hamm MW, Forrest DE, Wooten JT, (1990) Improved survival of heterotopic cardiac allografts in rats with dietary n-3 polyunsaturated fatty acids. Transplantation 50: 193-198.
26. Grimminger F, Grimm H, Fuhrer D, Papavassilis C, Lindemann G, et al. (1996) Omega-3 lipid infusion in a heart allotransplant model: Shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. Circulation 93: 365-371.
27. Ma H, Wang JH, Wang J, Li YS, Li JS, (2007) Fish oil ameliorates the allograft arteriosclerosis of intestine on rats. Pediatr Transplant 11: 173-179.
28. Murase N, Ye Q, Nalesnik MA, Demetris AJ, Abu-Elmagd K, et al. (2000) Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 70: 1632-1641.
29. Goodenough DA, (1999) Plugging the leaks. Proc Natl Acad. Sci USA 96: 319-321.
30. Zahraoui A, Louvard D, Galli T, (2000) Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol 151: F31-36.
31. Tsukita S, Furuse M, (1999) Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 9: 268-273.
32. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, et al. (2007) Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2: e662.
33. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, et al. (2007) Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941e8.
34. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 119-129.
35. Strober W, Fuss I, Mannon P, (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117: 514e21.
36. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
37. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
38. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW, (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 93: 3267-3275.
39. Li QR, Zhang Q, Wang CY, Li N, Li JS, (2008) Invasion of Enteropathogenic Escherichia coli into host cells through epithelial tight junctions. FEBS J 275: 6022-6032.
40. Zhang Q, Li QR, Wang CY, Liu XX, Li N, et al. (2010) Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo. Microb Pathogen 48: 28-34.